FDA Drug Recalls

Recalls / Class II

Class IID-1044-2013

Product

Sodium Thiosulfate 25%, 250 mg/mL (12.5 g/50mL), PF Sterile Solution for Injection, 50 mL Single Dose Vial, For Office Use Only, JCB Laboratories, Wichita, KS.

Affected lot / code info
Lot #: 130701@9, Exp 12/28/2013; 130709@6, Exp 01/05/2014; 130717@2, Exp 01/13/2014

Why it was recalled

Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Recalling firm

Firm
JCB Labs LLC
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
7335 W 33rd St N, N/A, Wichita, Kansas 67205-9368

Distribution

Quantity
1056 vials
Distribution pattern
Nationwide and Guam

Timeline

Recall initiated
2013-08-23
FDA classified
2013-09-13
Posted by FDA
2013-09-25
Terminated
2014-08-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1044-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls